Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2025-05-21 00:00:00 ET · period of report 2025-05-21 · accession 0001055726-25-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-21 | 2025-05-21 | INO | DANSEY ROGER D | Dir | M - OptEx | — | +2,167 | 8,916 | +32% | — |
| D | 2025-05-21 | 2025-05-21 | INO | DANSEY ROGER D | Dir | M - OptEx | $0.00 | -2,167 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-21 | M | A | 2,167 | — | 8,916 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. |
| 2 | Derivative | Restricted Stock Unit | 2025-05-21 | M | D | 2,167 | $0.00 | 0 | D | — · — to — | 2,167 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025. |